Ovid Therapeutics (OVID) Preferred Shares (2016 - 2023)

Ovid Therapeutics' Preferred Shares history runs 7 years deep, the most recent figure standing at $1.0 for Q3 2023.

• Quarterly Preferred Shares changed 0.0% year-over-year to $1.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $1.0 (changed 0.0% YoY) and the FY2022 annual result came in at $1.0, changed 0.0% from the prior year.
• Preferred Shares was $1.0 for Q3 2023 at Ovid Therapeutics, roughly flat from $1.0 in the prior quarter.
• Across five years, Preferred Shares topped out at $8.0 in Q4 2019 and bottomed at $1.0 in Q1 2021.
• A 5-year average of $2.74 and a median of $1.0 in 2021 frame the typical range for Preferred Shares.
• Annual changes were most pronounced in 2020 — Preferred Shares surged 166.67% — and 2021, when it sank 87.5%.
• Ovid Therapeutics' Preferred Shares stood at $8.0 in 2019, then plunged by 62.5% to $3.0 in 2020, then plunged by 66.67% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
• Business Quant data shows OVID's Preferred Shares at $1.0 in Q3 2023, $1.0 in Q2 2023, and $1.0 in Q1 2023.